<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24390337</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 2Apro targets MDA5 and MAVS in infected cells.</ArticleTitle><Pagination><StartPage>3369</StartPage><EndPage>3378</EndPage><MedlinePgn>3369-78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02712-13</ELocationID><Abstract><AbstractText Label="UNLABELLED">RIG-I-like receptors (RLRs) MDA5 and RIG-I are key players in the innate antiviral response. Upon recognition of viral RNA, they interact with MAVS, eventually inducing type I interferon production. The interferon induction pathway is commonly targeted by viruses. How enteroviruses suppress interferon production is incompletely understood. MDA5 has been suggested to undergo caspase- and proteasome-mediated degradation during poliovirus infection. Additionally, MAVS is reported to be cleaved during infection with coxsackievirus B3 (CVB3) by the CVB3 proteinase 3C(pro), whereas MAVS cleavage by enterovirus 71 has been attributed to 2A(pro). As yet, a detailed examination of the RLR pathway as a whole during any enterovirus infection is lacking. We performed a comprehensive analysis of crucial factors of the RLR pathway, including MDA5, RIG-I, LGP2, MAVS, TBK1, and IRF3, during infection of CVB3, a human enterovirus B (HEV-B) species member. We show that CVB3 inhibits the RLR pathway upstream of TBK1 activation, as demonstrated by limited phosphorylation of TBK1 and a lack of IRF3 phosphorylation. Furthermore, we show that MDA5, MAVS, and RIG-I all undergo proteolytic degradation in CVB3-infected cells through a caspase- and proteasome-independent manner. We convincingly show that MDA5 and MAVS cleavages are both mediated by CVB3 2A(pro), while RIG-I is cleaved by 3C(pro). Moreover, we show that proteinases 2A(pro) and 3C(pro) of poliovirus (HEV-C) and enterovirus 71 (HEV-A) exert the same functions. This study identifies a critical role of 2A(pro) by cleaving MDA5 and MAVS and shows that enteroviruses use a common strategy to counteract the interferon response in infected cells.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Human enteroviruses (HEVs) are important pathogens that cause a variety of diseases in humans, including poliomyelitis, hand, foot, and mouth disease, viral meningitis, cardiomyopathy, and more. Like many other viruses, enteroviruses target the host immune pathways to gain replication advantage. The MDA5/MAVS pathway is responsible for recognizing enterovirus infections in the host cell and leads to expression of type I interferons (IFN-I), crucial antiviral signaling molecules. Here we show that three species of HEVs all employ the viral proteinase 2A (2A(pro)) to proteolytically target MDA5 and MAVS, leading to an efficient blockade upstream of IFN-I transcription. These observations suggest that MDA5/MAVS antagonization is an evolutionarily conserved and beneficial mechanism of enteroviruses. Understanding the molecular mechanisms of enterovirus immune evasion strategies will help to develop countermeasures to control infections with these viruses in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langereis</LastName><ForeName>Martijn A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Lork</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Mai</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hato</LastName><ForeName>Stanleyson V</ForeName><Initials>SV</Initials></Author><Author ValidYN="Y"><LastName>Lanke</LastName><ForeName>Kjerstin</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Emdad</LastName><ForeName>Luni</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Bhoopathi</LastName><ForeName>Praveen</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Paul B</ForeName><Initials>PB</Initials></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Richard E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>van Kuppeveld</LastName><ForeName>Frank J M</ForeName><Initials>FJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI050237</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA097318</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01CA097318</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C505371">MAVS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C437968">PLAAT4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018168">Receptors, Retinoic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.29</RegistryNumber><NameOfSubstance UI="C057400">picornain 2A, Picornavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D053487">DEAD-box RNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053487" MajorTopicYN="N">DEAD-box RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="N">Interferon-Induced Helicase, IFIH1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018168" MajorTopicYN="N">Receptors, Retinoic Acid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24390337</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pii">JVI.02712-13</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stark GR, Darnell JEJ. 2012. The JAK-STAT pathway at twenty. Immunity 36:503&#x2013;514. 10.1016/j.immuni.2012.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.03.013</ArticleId><ArticleId IdType="pmc">PMC3909993</ArticleId><ArticleId IdType="pubmed">22520844</ArticleId></ArticleIdList></Reference><Reference><Citation>Goubau D, Deddouche S, Reis E, Sousa C. 2013. Cytosolic sensing of viruses. Immunity 38:855&#x2013;869. 10.1016/j.immuni.2013.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.05.007</ArticleId><ArticleId IdType="pmc">PMC7111113</ArticleId><ArticleId IdType="pubmed">23706667</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730&#x2013;737. 10.1038/ni1087</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1087</ArticleId><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, Fisher PB. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U. S. A. 99:637&#x2013;642. 10.1073/pnas.022637199</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.022637199</ArticleId><ArticleId IdType="pmc">PMC117358</ArticleId><ArticleId IdType="pubmed">11805321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D-C, Gopalkrishnan RV, Lin L, Randolph A, Valerie K, Pestka S, Fisher PB. 2004. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. Oncogene 23:1789&#x2013;1800. 10.1038/sj.onc.1207300</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207300</ArticleId><ArticleId IdType="pubmed">14676839</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U. S. A. 101:17264&#x2013;17269. 10.1073/pnas.0407639101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0407639101</ArticleId><ArticleId IdType="pmc">PMC535396</ArticleId><ArticleId IdType="pubmed">15563593</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo YM, Gale M, Jr, Akira S, Yonehara S, Kato A, Fujita T.
2005. 
Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol.
175:2851&#x2013;2858
http://www.jimmunol.org/content/175/5/2851.full.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">16116171</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth RB, Sun L, Ea C-KK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669&#x2013;682. 10.1016/j.cell.2005.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.012</ArticleId><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727&#x2013;740. 10.1016/j.molcel.2005.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.08.014</ArticleId><ArticleId IdType="pubmed">16153868</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981&#x2013;988. 10.1038/ni1243</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1243</ArticleId><ArticleId IdType="pubmed">16127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167&#x2013;1172. 10.1038/nature04193</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04193</ArticleId><ArticleId IdType="pubmed">16177806</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum A, Sachidanandam R, Garc&#xed;a-Sastre A. 2010. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. U. S. A. 107:16303&#x2013;16308. 10.1073/pnas.1005077107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1005077107</ArticleId><ArticleId IdType="pmc">PMC2941304</ArticleId><ArticleId IdType="pubmed">20805493</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang T-H, Liao C-L, Lin Y-L. 2006. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect. 8:157&#x2013;171. 10.1016/j.micinf.2005.06.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2005.06.014</ArticleId><ArticleId IdType="pubmed">16182584</ArticleId></ArticleIdList></Reference><Reference><Citation>Plumet S, Herschke F, Bourhis J-M, Valentin H, Longhi S, Gerlier D. 2007. Cytosolic 5&#x2032;-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2:e279. 10.1371/journal.pone.0000279</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000279</ArticleId><ArticleId IdType="pmc">PMC1804102</ArticleId><ArticleId IdType="pubmed">17356690</ArticleId></ArticleIdList></Reference><Reference><Citation>Malathi K, Saito T, Crochet N, Barton DJ, Gale M, Jr, Silverman RH. 2010. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 16:2108&#x2013;2119. 10.1261/rna.2244210</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2244210</ArticleId><ArticleId IdType="pmc">PMC2957051</ArticleId><ArticleId IdType="pubmed">20833746</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Hato SV, Langereis MA, Zoll J, Virgen-Slane R, Peisley A, Hur S, Semler BL, van Rij RP, van Kuppeveld FJM. 2012. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2:1187&#x2013;1196. 10.1016/j.celrep.2012.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.10.005</ArticleId><ArticleId IdType="pmc">PMC7103987</ArticleId><ArticleId IdType="pubmed">23142662</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Colonna M. 2008. MDA-5 recognition of a murine norovirus. PLoS Pathog. 4:e1000108. 10.1371/journal.ppat.1000108</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000108</ArticleId><ArticleId IdType="pmc">PMC2443291</ArticleId><ArticleId IdType="pubmed">18636103</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82:9829&#x2013;9838. 10.1128/JVI.01199-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01199-08</ArticleId><ArticleId IdType="pmc">PMC2566260</ArticleId><ArticleId IdType="pubmed">18667505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V, Ellegast J, Kim S, Brz&#xf3;zka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann K-KK, Schlee M, Endres S, Hartmann G. 2006. 5&#x2032;-Triphosphate RNA is the ligand for RIG-I. Science 314:994&#x2013;997. 10.1126/science.1132505</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1132505</ArticleId><ArticleId IdType="pubmed">17038590</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, Barchet W, Coch C, Janke M, Mihailovic A, Wardle G, Juranek S, Kato H, Kawai T, Poeck H, Fitzgerald KA, Takeuchi O, Akira S, Tuschl T, Latz E, Ludwig J, Hartmann G. 2009. Recognition of 5&#x2032; triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31:25&#x2013;34. 10.1016/j.immuni.2009.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.05.008</ArticleId><ArticleId IdType="pmc">PMC2824854</ArticleId><ArticleId IdType="pubmed">19576794</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K, Vakakis E, Kar S, Richer E, Evans GL, Triantafilou M. 2012. Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses. J. Cell Sci. 125:4761&#x2013;4769. 10.1242/jcs.103887</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.103887</ArticleId><ArticleId IdType="pubmed">22797917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hato SV, Ricour C, Schulte BM, Lanke KH, de Bruijni M, Zoll J, Melchers WJ, Michiels T, van Kuppeveld FJ. 2007. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell. Microbiol. 9:2921&#x2013;2930. 10.1111/j.1462-5822.2007.01006.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2007.01006.x</ArticleId><ArticleId IdType="pubmed">17991048</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB. 2011. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7:e1001311. 10.1371/journal.ppat.1001311</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001311</ArticleId><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Morrison JM, Drahos J, Gupta P, Sarkar D, Fisher PB, Racaniello VR. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81:3677&#x2013;3684. 10.1128/JVI.01360-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01360-06</ArticleId><ArticleId IdType="pmc">PMC1866155</ArticleId><ArticleId IdType="pubmed">17267501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R-L, Kao L-T, Lin S-J, Wang RY-L, Shih S-R. 2013. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One 8:e63431. 10.1371/journal.pone.0063431</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171&#x2013;176. 10.1016/j.virol.2009.06.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.06.045</ArticleId><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Drahos J, Racaniello VR. 2009. Cleavage of IPS-1 in cells infected with human rhinovirus. J. Virol. 83:11581&#x2013;11587. 10.1128/JVI.01490-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01490-09</ArticleId><ArticleId IdType="pmc">PMC2772720</ArticleId><ArticleId IdType="pubmed">19740998</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z. 2013. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 9:e1003231. 10.1371/journal.ppat.1003231</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebig HD, Ziegler E, Yan R, Hartmuth K, Klump H, Kowalski H, Blaas D, Sommergruber W, Frasel L, Lamphear B. 1993. Purification of two picornaviral 2A proteinases: interaction with eIF-4 gamma and influence on in vitro translation. Biochemistry 32:7581&#x2013;7588. 10.1021/bi00080a033</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00080a033</ArticleId><ArticleId IdType="pubmed">8338854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommergruber W, Ahorn H, Klump H, Seipelt J, Zoephel A, Fessl F, Krystek E, Blaas D, Kuechler E, Liebig HD. 1994. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif. Virology 198:741&#x2013;745. 10.1006/viro.1994.1089</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1089</ArticleId><ArticleId IdType="pubmed">8291255</ArticleId></ArticleIdList></Reference><Reference><Citation>White JP, Cardenas AM, Marissen WE, Lloyd RE. 2007. Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe 2:295&#x2013;305. 10.1016/j.chom.2007.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2007.08.006</ArticleId><ArticleId IdType="pubmed">18005751</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Sarkar D, Su Z, Barber GN, DeSalle R, Racaniello VR, Fisher PB. 2009. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol. Ther. 124:219&#x2013;234. 10.1016/j.pharmthera.2009.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2009.06.012</ArticleId><ArticleId IdType="pmc">PMC3165056</ArticleId><ArticleId IdType="pubmed">19615405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu-Martinez NM, Joachims M, Lloyd RE. 2002. Efficient cleavage of ribosome-associated poly(A)-binding protein by enterovirus 3C protease. J. Virol. 76:2062&#x2013;2074. 10.1128/jvi.76.5.2062-2074.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.5.2062-2074.2002</ArticleId><ArticleId IdType="pmc">PMC135927</ArticleId><ArticleId IdType="pubmed">11836384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoll J, Melchers WJG, Galama JMD, van Kuppeveld FJM. 2002. The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-&#x3ba;B. J. Virol. 76:9664&#x2013;9672. 10.1128/JVI.76.19.9664-9672.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.19.9664-9672.2002</ArticleId><ArticleId IdType="pmc">PMC136484</ArticleId><ArticleId IdType="pubmed">12208945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W. 2013. Negative regulation of TBK1-mediated antiviral immunity. FEBS Lett. 587:542&#x2013;548. 10.1016/j.febslet.2013.01.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2013.01.052</ArticleId><ArticleId IdType="pmc">PMC7094513</ArticleId><ArticleId IdType="pubmed">23395611</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau DHW, Yuan J, Zhang H, Cheung P, Lim T, Liu Z, Sall A, Yang D. 2007. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 12:513&#x2013;524. 10.1007/s10495-006-0013-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-006-0013-0</ArticleId><ArticleId IdType="pubmed">17195095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Morace G, Gauss-M&#xfc;ller V, Kusov Y. 2007. Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation. Nucleic Acids Res. 35:5975&#x2013;5984. 10.1093/nar/gkm645</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm645</ArticleId><ArticleId IdType="pmc">PMC2034478</ArticleId><ArticleId IdType="pubmed">17726047</ArticleId></ArticleIdList></Reference><Reference><Citation>Marissen WE, Lloyd RE. 1998. Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol. Cell. Biol. 18:7565&#x2013;7574</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109337</ArticleId><ArticleId IdType="pubmed">9819442</ArticleId></ArticleIdList></Reference><Reference><Citation>Joachims M, Van Breugel PC, Lloyd RE. 1999. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J. Virol. 73:718&#x2013;727</Citation><ArticleIdList><ArticleId IdType="pmc">PMC103879</ArticleId><ArticleId IdType="pubmed">9847378</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili P, Harris K, Wimmer E, Dasgupta A. 1996. Inhibition of basal transcription by poliovirus: a virus-encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro. J. Virol. 70:2922&#x2013;2929</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190150</ArticleId><ArticleId IdType="pubmed">8627767</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR, Barber GN. 2000. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. Virol. 74:1513&#x2013;1523. 10.1128/JVI.74.3.1513-1523.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.3.1513-1523.2000</ArticleId><ArticleId IdType="pmc">PMC111487</ArticleId><ArticleId IdType="pubmed">10627563</ArticleId></ArticleIdList></Reference><Reference><Citation>Watters K, Palmenberg AC. 2011. Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes. J. Virol. 85:10874&#x2013;10883. 10.1128/JVI.00718-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00718-11</ArticleId><ArticleId IdType="pmc">PMC3187490</ArticleId><ArticleId IdType="pubmed">21835805</ArticleId></ArticleIdList></Reference><Reference><Citation>Papon L, Oteiza A, Imaizumi T, Kato H, Brocchi E, Lawson TG, Akira S, Mechti N. 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393:311&#x2013;318. 10.1016/j.virol.2009.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.08.009</ArticleId><ArticleId IdType="pubmed">19733381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, Hoshino K, Takeda K, Akira S. 2004. The roles of two I B kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:1641&#x2013;1650. 10.1084/jem.20040520</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20040520</ArticleId><ArticleId IdType="pmc">PMC2212809</ArticleId><ArticleId IdType="pubmed">15210742</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao S-MM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491&#x2013;496. 10.1038/ni921</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, ten Oever BR, Grandvaux N, Zhou G-P, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148&#x2013;1151. 10.1126/science.1081315</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1081315</ArticleId><ArticleId IdType="pubmed">12702806</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau T-L, Gioia R, Gatot J-S, Patrascu F, Carpentier I, Chapelle J-P, O'Neill L, Beyaert R, Piette J, Chariot A. 2008. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem. Sci. 33:171&#x2013;180. 10.1016/j.tibs.2008.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2008.01.002</ArticleId><ArticleId IdType="pubmed">18353649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidsky PV, Hato S, Bardina MV, Aminev AG, Palmenberg AC, Sheval EV, Polyakov VY, van Kuppeveld FJ, Agol VI. 2006. Nucleocytoplasmic traffic disorder induced by cardioviruses. J. Virol. 80:2705&#x2013;2717. 10.1128/JVI.80.6.2705-2717.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.6.2705-2717.2006</ArticleId><ArticleId IdType="pmc">PMC1395435</ArticleId><ArticleId IdType="pubmed">16501080</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov G, Lidsky P, Mikitas O, Egger D, Lukyanov K, Bienz K, Agol V. 2004. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J. Virol. 78:10166&#x2013;10177. 10.1128/JVI.78.18.10166-10177.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.18.10166-10177.2004</ArticleId><ArticleId IdType="pmc">PMC514989</ArticleId><ArticleId IdType="pubmed">15331749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>